Amber Salzman, Ph.D.

"We are grateful for our dedicated team and everyone who has continued to support us at Epic Bio. Thank you for a fantastic 2022, and we'll see you in the New Year. #team #thankyou #grateful #epicbio #genomics "

"Meet Dr. Alexandra Collin de l’Hortet, head of therapeutics at Epic Bio. Dr. Collin brings more than ten years of experience to the team, from discovery to Phase III clinical trials. #womeninscience "

"We are pleased to share that Epic Bio's CEO, Dr. Amber Salzman, has been chosen by Endpoints News as one of their top 20 Women in Biopharma R&D 2022. Learn more here: https://endpts.com/special-report-2022-meet-20-women-blazing-trails-in-biopharma-rd/ "